AIM2 and hepatocellular carcinoma: To further define whether lack of AIM2 expression in HCC cells contributed to HCC progression through loss of suppression of mTOR-S6K1 pathway, we investigated the effect of mTOR inhibitor, rapamycin on the malignant behaviors of AIM2-knocked down HCC cells.